Pro-inflammatory cytokines of rat vasculature in DOCA-salt treatment

Molecular Biology Reports

Volumn 37, Issue 4, 2010, Pages 2111-2115

  Seifi, Behjat ^a   Kadkhodaee, Mehri ^a   Xu, Jie ^b   Soleimani, Manoocher ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Aorta; Hypertension; IL 6; TNF a

Indexed keywords

CYTOKINE; DEOXYCORTICOSTERONE ACETATE; INTERLEUKIN 6; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; DEOXYCORTICOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; HYPERTENSION; KIDNEY; MALE; NEPHRECTOMY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; TISSUE DISTRIBUTION; VASCULARIZATION; ANIMAL; BLOOD PRESSURE; BLOOD VESSEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT; SYSTOLE; TIME;

RATTUS;

ANIMALS; AORTA; BLOOD PRESSURE; BLOOD VESSELS; DESOXYCORTICOSTERONE; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYSTOLE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953174258     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9676-2     Document Type: Article

References (15)

1. Kim HY, Kang YJ, Song IH, Choi HC, Kim HS (2008) Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 31:515-523. doi:10.1291/hypres.31.515 (Pubitemid 351597506)
2. Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND (2005) Early and sustained inhibition of nuclear factor-kappa B prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther 315:51-57. doi:10.1124/jpet. 105.088062
3. Obst M, Gross V, Luft FC (2004) Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice. J Hypertens 22:1889-1894. doi:10.1097/00004872-200410000-00010 (Pubitemid 39336671)
4. Elmarakby AA, Quigley JE, Pollock DM, Imig JD (2006) Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 47:557-562. doi:10.1161/01.HYP. 0000198545.01860.90
5. Guzik TJ, Hoch NE, Brown KA et al (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204:2449-2460. doi:10.1084/jem.2007 0657
6. Miyazawa K, Fukuyama J, Misawa K, Hamano S, Ujiie A (1996) Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells. Atherosclerosis 121:167-173. doi:10.1016/0021-9150(95) 05709-9 (Pubitemid 26125973)
7. Kagitani S, Ueno H, Hirade S, Takahashi T, Takata M, Inoue H (2004) Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats. J Hypertens 22:1007-1015. doi:10.1097/00004 872-200405000-00024
8. Navarro JF, Milena FJ, Mora C, Leon C, Garcia J (2006) Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: Effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol 26:562-570. doi: 10.1159/000098004 (Pubitemid 46143878)
9. Navarro JF, Mora-Fernandez C (2006) The role of TNF-alpha in diabetic nephropathy: Pathogenic and therapeutic implications. Cytokine Growth Factor Rev 17:441-450. doi:10.1016/j.cytogfr. 2006.09.011
10. Dahl LK, Heine M, Tassinari L (1963) Effects of chronic excess salt ingestion. Role of genetic factors in both doca-salt and renal hypertension. J Exp Med 118:605-617. doi:10.1084/jem.118.4. 605
11. Coles B, Fielding CA, Rose-John S, Scheller J, Jones SA, O'Donnell VB (2007) Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo. Am J Pathol 171:315-325. doi:10.2353/ajpath.2007. 06 1078 (Pubitemid 47339248)
12. Fernandez-Real JM, Vayreda M, Richart C et al (2001) Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86:1154-1159. doi:10.1210/jc.86.3.1154 (Pubitemid 32322997)
13. Vazquez-Oliva G, Fernandez-Real JM, Zamora A, Vilaseca M, Badimon L (2005) Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects. J Hum Hypertens 19:457-462. doi:10.1038/sj.jhh.1001845 (Pubitemid 40767181)
14. Orshal JM, Khalil RA (2004) Reduced endothelial NO-cGMPmediated vascular relaxation and hypertension in IL-6-infused pregnant rats. Hypertension 43:434-444. doi:10.1161/01.HYP. 0000113044.46326.98
15. Francis J, Beltz T, Johnson AK, Felder RB (2003) Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor- alpha in normal rats. Am J Physiol 285:R1402-R1409. doi: 10.1152/ajpregu.00027.2003